SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 31 filers reported holding SQZ BIOTECHNOLOGIES CO in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $202,003 | -70.3% | 2,517,173 | 0.0% | 0.00% | -75.0% |
| Q2 2023 | $679,637 | -51.8% | 2,517,173 | 0.0% | 0.00% | -55.6% |
| Q1 2023 | $1,409,617 | -24.3% | 2,517,173 | 0.0% | 0.01% | -30.8% |
| Q4 2022 | $1,862,708 | -67.5% | 2,517,173 | 0.0% | 0.01% | -69.0% |
| Q3 2022 | $5,739,000 | -28.3% | 2,517,173 | 0.0% | 0.04% | -22.2% |
| Q2 2022 | $8,005,000 | -34.2% | 2,517,173 | -0.4% | 0.05% | -19.4% |
| Q1 2022 | $12,162,000 | -46.2% | 2,528,477 | -0.0% | 0.07% | -40.7% |
| Q4 2021 | $22,586,000 | -38.1% | 2,529,272 | -0.0% | 0.11% | -41.8% |
| Q3 2021 | $36,478,000 | -0.2% | 2,529,633 | -0.0% | 0.19% | +56.5% |
| Q2 2021 | $36,557,000 | +6.0% | 2,529,929 | +0.4% | 0.12% | +2.5% |
| Q1 2021 | $34,476,000 | +45868.0% | 2,520,186 | +97279.7% | 0.12% | – |
| Q4 2020 | $75,000 | – | 2,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NanoDimension, Inc. | 1,445,221 | $6,952,000 | 15.25% |
| 683 Capital Management, LLC | 2,098,815 | $10,096,000 | 0.54% |
| Artal Group S.A. | 1,606,309 | $7,726,000 | 0.32% |
| Sandy Cove Advisors, LLC | 51,707 | $249,000 | 0.21% |
| MAVERICK CAPITAL LTD | 1,056,786 | $5,083,000 | 0.09% |
| ACT CAPITAL MANAGEMENT, LLC | 16,000 | $77,000 | 0.08% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,528,477 | $12,162,000 | 0.07% |
| Temasek Holdings (Private) Ltd | 2,758,169 | $13,266,793 | 0.06% |
| Alphabet Inc. | 103,929 | $500,000 | 0.02% |
| Baldrige Asset Management LLC | 5,000 | $24,000 | 0.01% |